Notice of Annual General Meeting for Swedish Orphan Biovitrum AB: Key Details and Agenda The notice of the upcoming Annual General Meeting for Swedish Orphan Biovitrum AB outlines essential participant details and agenda items for stakeholders.

Notice of Annual General Meeting for Swedish Orphan Biovitrum AB: Key Details and Agenda #Sweden #Stockholm #Sobi #Annual_General_Meeting #Swedish_Orphan_Biovitrum

Sobi Reports Shareholder Updates Following Recent Share Conversions On September 30, 2025, Sobi announced its total shares and significant conversions affecting its stock structure, impacting voting power.

Sobi Reports Shareholder Updates Following Recent Share Conversions #Sweden #Stockholm #Sobi #shares #Swedish_Orphan_Biovitrum

Sobi Successfully Completes Class C Share Issues to Strengthen Operations Sobi's recent resolutions aim to enhance operational capacity through the successful issuance and repurchase of Class C shares facilitating incentive programmes.

Sobi Successfully Completes Class C Share Issues to Strengthen Operations #Sweden #Stockholm #Sobi #Swedish_Orphan_Biovitrum #class_C_shares

Sobi's Board Approves Share Buyback to Secure Incentive Commitments Swedish Orphan Biovitrum (Sobi) has initiated a share repurchase program, following resolutions from its Annual General Meeting to uphold commitments towards incentive programs.

Sobi's Board Approves Share Buyback to Secure Incentive Commitments #Sweden #Stockholm #Sobi #Incentive_Programs #Swedish_Orphan_Biovitrum

Sobi Unveils 2024 Annual and Sustainability Report Highlighting Innovations for Rare Diseases Swedish Orphan Biovitrum AB (Sobi®) releases its Annual and Sustainability Report, detailing achievements and commitments in healthcare innovations for rare diseases.

Sobi Unveils 2024 Annual and Sustainability Report Highlighting Innovations for Rare Diseases #Sweden #Stockholm #Sobi #Rare_Diseases #Swedish_Orphan_Biovitrum